» Articles » PMID: 36700956

Whole-tumor Amide Proton Transfer-weighted Imaging Histogram Analysis to Predict Pathological Extramural Venous Invasion in Rectal Adenocarcinoma: a Preliminary Study

Overview
Journal Eur Radiol
Specialty Radiology
Date 2023 Jan 26
PMID 36700956
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate amide proton transfer-weighted (APTw)-derived whole-tumor histogram analysis parameters in predicting pathological extramural venous invasion (pEMVI) positive status of rectal adenocarcinoma (RA).

Methods: Preoperative MR including APTw imaging of 125 patients with RA (mean 61.4 ± 11.6 years) were retrospectively analyzed. Two radiologists reviewed each case's EMVI status based on the MR-based modified 5-point scale system with conventional MR images. The APTw histogram parameters of primary tumors were obtained automatically using whole-tumor volume histogram analysis. The independent risk factors markedly correlated with pEMVI-positive status were assessed using univariate and multivariate logistic regression analyses. Diagnosis performance was assessed by receiver operating characteristic curve (ROC) analysis. The AUCs were compared using the Delong method.

Results: Univariate analysis demonstrated that MR-tumor (T) stage, MR-lymph node (N) stage, APTw-10%, APTw-90%, interquartile range, APTw-minimum, APTw-maximum, APTw-mean, APTw-median, entropy, kurtosis, mean absolute deviation (MAD), and robust MAD were significantly related to pEMVI-positive status (all p < 0.05). Multivariate analysis demonstrated that MR-T stage (OR = 4.864, p = 0.018), MR-N stage (OR = 4.967, p = 0.029), interquartile range (OR = 0.892, p = 0.037), APT-minimum (OR = 1.046, p = 0.031), entropy (OR = 11.604, p = 0.006), and kurtosis (OR = 1.505, p = 0.007) were the independent risk factors enabling prediction of pEMVI-positive status. The AUCs for diagnostic ability of conventional MRI assessment, the APTw histogram model, and the combined model (including APTw histogram and clinical variables) were 0.785, 0.853, and 0.918, respectively. The combined model outperformed the APTw histogram model (p = 0.013) and the conventional MRI assessment (p = 0.006).

Conclusions: Whole-tumor histogram analysis of APTw images combined with clinical factors showed better diagnosis efficiency in predicting EMVI involvement in RA.

Key Points: • Rectal adenocarcinomas with pEMVI-positive status are typically associated with higher APTw-SI values. • APTw-minimum, interquartile range, entropy, kurtosis, MR-T stage, and MR-N stage are the independent risk factors for EMVI involvement. • The best prediction for EMVI involvement was obtained with a combined model of APTw histogram and clinical variables (area under the curve, 0.918).

Citing Articles

Enhancing the role of MRI in rectal cancer: advances from staging to prognosis prediction.

Gong X, Ye Z, Shen Y, Song B Eur Radiol. 2025; .

PMID: 40045072 DOI: 10.1007/s00330-025-11463-x.


Added value of amide proton transfer-weighted magnetic resonance imaging to Prostate Imaging Reporting and Data System version 2.1 in differentiating clinically significant prostate cancer.

Ye Y, Gong Z, Song Y, Yv L, Liu Z, Ying H Quant Imaging Med Surg. 2024; 14(12):9036-9048.

PMID: 39698702 PMC: 11652010. DOI: 10.21037/qims-24-1121.


Histogram analysis based on intravoxel incoherent motion diffusion-weighted imaging for determining the perineural invasion status of rectal cancer.

He R, Song G, Fu J, Dou W, Li A, Chen J Quant Imaging Med Surg. 2024; 14(8):5358-5372.

PMID: 39144004 PMC: 11320521. DOI: 10.21037/qims-23-1614.


Amide proton transfer-weighted MRI for assessing rectal adenocarcinoma T-staging and perineural invasion: a prospective study.

Zhang C, Chen J, Liu Y, Yang Y, Xu Y, You R Eur Radiol. 2024; 35(2):968-978.

PMID: 39122854 DOI: 10.1007/s00330-024-11000-2.


Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.

Xiang Y, Zhang Q, Chen X, Sun H, Li X, Wei X Eur Radiol. 2024; 34(10):6820-6830.

PMID: 38491129 DOI: 10.1007/s00330-024-10696-6.

References
1.
Yeo D, Oh S, Lee M, Lee I, Lee Y, Oh S . The development and validation of a predictive model for recurrence in rectal cancer based on radiological and clinicopathological data. Eur Radiol. 2021; 31(11):8586-8596. DOI: 10.1007/s00330-021-07920-y. View

2.
Zhao Q, Wan L, Zou S, Zhang C, E T, Yang Y . Prognostic risk factors and survival models for T3 locally advanced rectal cancer: what can we learn from the baseline MRI?. Eur Radiol. 2021; 31(7):4739-4750. DOI: 10.1007/s00330-021-08045-y. View

3.
Zhang X, Wang S, Li X, Wang Y, Shi Y, Wang L . MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018; 289(3):677-685. DOI: 10.1148/radiol.2018172889. View

4.
Wo J, Anker C, Ashman J, Bhadkamkar N, Bradfield L, Chang D . Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2020; 11(1):13-25. DOI: 10.1016/j.prro.2020.08.004. View

5.
Kennedy E, Simunovic M, Jhaveri K, Kirsch R, Brierley J, Drolet S . Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial. JAMA Oncol. 2019; 5(7):961-966. PMC: 6583831. DOI: 10.1001/jamaoncol.2019.0186. View